Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume -, Issue -, Pages kev269
Publisher
Oxford University Press (OUP)
Online
2015-07-25
DOI
10.1093/rheumatology/kev269
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease
- (2015) Luca Cantarini et al. AUTOIMMUNITY REVIEWS
- Efficacy and safety of biological agents in adult-onset Still’s disease
- (2015) G Cavalli et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease
- (2014) Maria Giulia Cangi et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: A french multicenter study
- (2014) Antoine Néel et al. AUTOIMMUNITY REVIEWS
- Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
- (2014) E. L. Diamond et al. BLOOD
- Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease
- (2014) Andrea Vambutas et al. JOURNAL OF CLINICAL INVESTIGATION
- An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
- (2014) Scott W Canna et al. NATURE GENETICS
- Therapeutic Role of Anakinra, an Interleukin-1 Receptor Antagonist, in the Management of Secondary Hemophagocytic Lymphohistiocytosis/Sepsis/Multiple Organ Dysfunction/Macrophage Activating Syndrome in Critically Ill Children*
- (2014) Surender Rajasekaran et al. Pediatric Critical Care Medicine
- Oncogene-Induced Senescence as a New Mechanism of Disease: The Paradigm of Erdheim–Chester Disease
- (2014) Giulio Cavalli et al. Frontiers in Immunology
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
- (2013) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
- (2013) Benjamin Wallace Van Tassell et al. AMERICAN JOURNAL OF CARDIOLOGY
- Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations
- (2013) Jette Primdahl et al. ANNALS OF THE RHEUMATIC DISEASES
- The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases
- (2013) Giulio Cavalli et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra treatment in drug-resistant Behcet’s disease: a case series
- (2013) Luca Cantarini et al. CLINICAL RHEUMATOLOGY
- Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1 Antibody, in Patients With Type 2 Diabetes
- (2013) J. Sloan-Lancaster et al. DIABETES CARE
- Erdheim–Chester disease with cardiac involvement successfully treated with anakinra
- (2013) Ammar M. Killu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Successful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist protein
- (2013) Audrey Courcoul et al. JOINT BONE SPINE
- Interleukin-1 blockade in refractory giant cell arteritis
- (2013) Kim-Heang Ly et al. JOINT BONE SPINE
- Efficacy and safety of canakinumab in urticarial vasculitis: An open-label study
- (2013) Karoline Krause et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator
- (2013) Robert A Terkeltaub et al. ARTHRITIS RESEARCH & THERAPY
- Topical Interleukin 1 Receptor Antagonist for Treatment of Dry Eye Disease
- (2013) Francisco Amparo et al. JAMA Ophthalmology
- Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study
- (2013) Sebastiaan J. Vastert et al. Arthritis & Rheumatology
- A pilot study of IL-1 inhibition in acute calcific periarthritis of the shoulder
- (2012) Pascal Zufferey et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome
- (2012) Heleen D de Koning et al. ANNALS OF THE RHEUMATIC DISEASES
- A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation
- (2012) Sophie Cohen et al. ANNALS OF THE RHEUMATIC DISEASES
- Blocking Interleukin-1 as a Novel Therapeutic Strategy for Secondary Prevention of Cardiovascular Events
- (2012) Antonio Abbate et al. BIODRUGS
- Interleukin-1β Is Crucial for the Induction of Coronary Artery Inflammation in a Mouse Model of Kawasaki Disease
- (2012) Youngho Lee et al. CIRCULATION
- Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
- (2012) C. Cavelti-Weder et al. DIABETES CARE
- Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial
- (2012) A. Rissanen et al. DIABETES OBESITY & METABOLISM
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
- (2012) Benjamin W. Van Tassell et al. PLoS One
- Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study
- (2012) H. Ralph Schumacher et al. ARTHRITIS CARE & RESEARCH
- Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study
- (2011) Ahmet Gül et al. ANNALS OF THE RHEUMATIC DISEASES
- Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
- (2011) N. Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
- (2011) J. B. Kuemmerle-Deschner et al. ANNALS OF THE RHEUMATIC DISEASES
- On-demand anakinra treatment is effective in mevalonate kinase deficiency
- (2011) E. J. Bodar et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment of pediatric Erdheim-Chester disease with interleukin-1-targeting drugs
- (2011) T. A. Tran et al. ARTHRITIS AND RHEUMATISM
- A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
- (2011) Nicolino Ruperto et al. ARTHRITIS AND RHEUMATISM
- Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: A prospective, open-label, dose-escalation study
- (2011) Ariel C. Bulua et al. ARTHRITIS AND RHEUMATISM
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
- (2011) Rieke Alten et al. BMC MUSCULOSKELETAL DISORDERS
- Hyper-IgD syndrome or mevalonate kinase deficiency
- (2011) Monique Stoffels et al. CURRENT OPINION IN RHEUMATOLOGY
- Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
- (2011) Greta Guarda et al. IMMUNITY
- Treatment with Anakinra Improves Disposition Index But Not Insulin Sensitivity in Nondiabetic Subjects with the Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
- (2011) Edwin J. P. van Asseldonk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- IL-1 Is Overexpressed and Aberrantly Regulated in Corticosteroid Nonresponders with Autoimmune Inner Ear Disease
- (2011) S. Pathak et al. JOURNAL OF IMMUNOLOGY
- IL-1 and IL-1 Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
- (2011) P. Rider et al. JOURNAL OF IMMUNOLOGY
- Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure
- (2011) K. Stankovic Stojanovic et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1
- (2011) Y. Berda-Haddad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-1 Targeting Drugs in Familial Mediterranean Fever: A Case Series and a Review of the Literature
- (2011) Ulrich Meinzer et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee
- (2011) Stanley B Cohen et al. ARTHRITIS RESEARCH & THERAPY
- Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study
- (2011) Isabelle Koné-Paut et al. ARTHRITIS RESEARCH & THERAPY
- Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
- (2011) Naomi Schlesinger et al. ARTHRITIS RESEARCH & THERAPY
- Current Status of Understanding the Pathogenesis and Management of Patients With NOMID/CINCA
- (2011) Raphaela Goldbach-Mansky Current Rheumatology Reports
- IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease
- (2010) L Naumann et al. ANNALS OF THE RHEUMATIC DISEASES
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- How interleukin-1β induces gouty arthritis
- (2010) Charles A. Dinarello ARTHRITIS AND RHEUMATISM
- Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease
- (2010) Stefano Franchini et al. ARTHRITIS AND RHEUMATISM
- Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study
- (2010) Alexander So et al. ARTHRITIS AND RHEUMATISM
- Engagement of fatty acids with toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis
- (2010) Leo A. B. Joosten et al. ARTHRITIS AND RHEUMATISM
- Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease
- (2010) A. Aouba et al. BLOOD
- Anti-inflammatory Agents: Present and Future
- (2010) Charles A. Dinarello CELL
- The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity
- (2010) Rinke Stienstra et al. Cell Metabolism
- Inflammasome and IL-1β-Mediated Disorders
- (2010) Hal M. Hoffman et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Interleukin-1β modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse
- (2010) Antonio Abbate et al. EUROPEAN JOURNAL OF HEART FAILURE
- The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
- (2010) I. Solovic et al. EUROPEAN RESPIRATORY JOURNAL
- Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome
- (2010) Tassadit Aït-Abdesselam et al. JOINT BONE SPINE
- Follow-Up and Quality of Life of Patients with Cryopyrin-Associated Periodic Syndromes Treated with Anakinra
- (2010) Loredana Lepore et al. JOURNAL OF PEDIATRICS
- Anti-Interleukin 1 Treatment for Patients with Familial Mediterranean Fever Resistant to Colchicine: Table 1.
- (2010) SEZA ÖZEN et al. JOURNAL OF RHEUMATOLOGY
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
- (2010) Seth L Masters et al. NATURE IMMUNOLOGY
- Neurologic manifestations of the cryopyrin-associated periodic syndrome
- (2010) J. L. Kitley et al. NEUROLOGY
- Differential release of chromatin-bound IL-1 discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation
- (2010) I. Cohen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients
- (2010) P. M. Miettunen et al. RHEUMATOLOGY
- Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra—case report and review
- (2010) Stefanie Hennig et al. RHEUMATOLOGY INTERNATIONAL
- Erosive osteoarthritis of the hand: clinical experience with anakinra
- (2009) L Bacconnier et al. ANNALS OF THE RHEUMATIC DISEASES
- Demyelinating events in rheumatoid arthritis after drug exposures
- (2009) S. Bernatsky et al. ANNALS OF THE RHEUMATIC DISEASES
- The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
- (2009) R Terkeltaub et al. ANNALS OF THE RHEUMATIC DISEASES
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1β receptor antagonist (anakinra): An unrecognized autoinflammatory disease?
- (2009) Paolo Picco et al. ARTHRITIS AND RHEUMATISM
- Functional analysis of the osteoarthritis susceptibility-associatedGDF5regulatory polymorphism
- (2009) Rainer J. Egli et al. ARTHRITIS AND RHEUMATISM
- Inflammatory arthritis in caspase 1 geneâdeficient mice: Contribution of proteinase 3 to caspase 1âindependent production of bioactive interleukin-1β
- (2009) Leo A. B. Joosten et al. ARTHRITIS AND RHEUMATISM
- Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double-blind, placebo-controlled study
- (2009) X. Chevalier et al. ARTHRITIS AND RHEUMATISM
- Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome
- (2009) Bénédicte Neven et al. ARTHRITIS AND RHEUMATISM
- Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease
- (2009) Yelda Bilginer et al. CLINICAL RHEUMATOLOGY
- Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
- (2009) C. M. Larsen et al. DIABETES CARE
- Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis
- (2009) I Ikonomidis et al. HEART
- Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure
- (2009) Nadia Announ et al. JOINT BONE SPINE
- In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
- (2009) Helen J. Lachmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anakinra for Rheumatoid Arthritis: A Systematic Review
- (2009) M. MERTENS et al. JOURNAL OF RHEUMATOLOGY
- The role of microparticles in the pathogenesis of rheumatic diseases
- (2009) Christian Beyer et al. Nature Reviews Rheumatology
- An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
- (2009) Ivona Aksentijevich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Autoinflammatory Disease Due to Homozygous Deletion of theIL1RNLocus
- (2009) Sreelatha Reddy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1 in human monocytes and multiple sclerosis
- (2009) D. Burger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular inflammation: Underpinnings of aging and age-related diseases
- (2008) Hae Young Chung et al. AGEING RESEARCH REVIEWS
- Successful treatment of resistant pseudogout with anakinra
- (2008) Dennis McGonagle et al. ARTHRITIS AND RHEUMATISM
- The pattern of response to anti–interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis
- (2008) Marco Gattorno et al. ARTHRITIS AND RHEUMATISM
- Persistent efficacy of anakinra in patients with tumor necrosis factor receptor–associated periodic syndrome
- (2008) M. Gattorno et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
- (2008) Hal M. Hoffman et al. ARTHRITIS AND RHEUMATISM
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
- (2008) Ignatios Ikonomidis et al. CIRCULATION
- IL-1 blockade in Schnitzler syndrome: Ex vivo findings correlate with clinical remission
- (2008) John G. Ryan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation
- (2008) C. Moser et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A case of macrophage activation syndrome successfully treated with anakinra
- (2008) Alison Kelly et al. Nature clinical practice. Rheumatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now